News
Sixty seconds on . . . meldonium
BMJ 2016; 352 doi: https://doi.org/10.1136/bmj.i1420 (Published 09 March 2016) Cite this as: BMJ 2016;352:i1420
- Nigel Hawkes
- London
Poor Maria Sharapova. A drug she has been taking for a decade turns out to be a banned substance. Now she’s lost her Nike and Tag Heuer sponsorships
Yes, definitely a double fault for the Russian tennis star.
But was it an unforced error, as the tennis cognoscenti say?
Meldonium (also known as mildronate) is a drug made in Latvia used for treating heart failure, angina, and myocardial infarction. It isn’t licensed in the United States or Europe.
Does Sharapova have any of these conditions?
We don’t know, but it seems unlikely. She has said that she had magnesium …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.